Jeffrey L. Edwards - 21 Apr 2026 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Reporting relationship: Director
Issuer ticker: BIO
Reported as of: 21 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Apr 2026, 15:24:59 UTC
Prior SEC filing: 06 Jun 2025
Next SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey L. Edwards

Key filing fact

Jeffrey L. Edwards filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 23 Apr 2026.

Key facts

This page summarizes Jeffrey L. Edwards's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 23 Apr 2026, 15:24.

Change

Previous filing in this sequence was filed on 06 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001190642 Primary reporting owner

EDWARDS JEFFREY L

Relationship: Director
Address: C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES
Signature: /s/ Jeffrey L. Edwards
Signature date: 23 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value
Shares: +407
Change %: +132%
Price: $0.000000^*
Shares after: 715
Date: 21 Apr 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +369
Change %
Price: $0.000000^*
Shares after: 369
Date: 21 Apr 2026
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 369
Exercise price: $0.000000
Footnotes: F2, F3

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -407
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 21 Apr 2026
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 407
Exercise price: $0.000000
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F3

The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.